Evidence map›Paper›PMID 32788743›Full record

ArticleScientific reports2020

Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus.

Xingfei Pan, Jingsi Chen, Liyang Zhou, Xueting Ou, Fang He, Yifen Liu, Shuo Zheng, Haibin Wang, Bin Cao, Zhijian Wang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. [Research progress on clinical antiviral treatment of chronic hepatitis B in children].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

Xingfei Pan *Department of Infectious Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Jingsi Chen *Department of Fetal Medicine and Prenatal Diagnosis, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Liyang ZhouDepartment of Infectious Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Xueting OuDepartment of Infectious Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Fang HeThe Medical Centre for Critical Pregnant Women in Guangzhou, Guangzhou, China.
Yifen LiuThe Medical Centre for Critical Pregnant Women in Guangzhou, Guangzhou, China.
Shuo ZhengDepartment of Infectious Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Haibin WangFujian Provincial Laboratory for Reproductive Health Research, School of Medicine, Xiamen University, Xiamen, China.
Bin CaoFujian Provincial Laboratory for Reproductive Health Research, School of Medicine, Xiamen University, Xiamen, China.
Zhijian WangDepartment of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Huishu LiuDepartment of Obstetrics and Gynecology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Guocheng LiuDepartment of Obstetrics and Gynecology, Guangdong Provincial Maternal and Children's Hospital, Guangzhou, China.
Zhenyu HuangDepartment of Obstetrics and Gynecology, Beijing TsingHua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Guanxin ShenDepartment of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shiliang LiuSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Dunjin ChenKey Laboratory for Major Obstetric Diseases of Guangdong Province, Guangzhou, China. gzdrchen@gzhmu.edu.cn.
Guangzhou Medical University · CNGuangzhou Women and Children Medical Center · CNThird Affiliated Hospital of Guangzhou Medical University · CNXiamen University · CNGuangdong Province Women and Children Hospital · CNHuazhong University of Science and Technology · CNNanfang Hospital · CNTsinghua University · CNUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few studies were conducted to assess safety and efficacy of continuous antiviral therapy administrated from preconception. In the present study, 136 eligible women with chronic HBV infection were recruited, and assigned to active chronic hepatitis B (CHB) (Group A, B or C) or chronic HBV carrier (Group D). Antiviral therapy was administrated in preconception (Group A), in early (Group B) or late pregnancy (Group C and Group D). Immunoprophylaxis was administrated to all infants. Mothers' HBV status and ALT were assessed at delivery and 7 months postpartum. Offspring's HBV status was examined at 7 months old. Group A women showed low HBV DNA level and normal ALT throughout pregnancy. All women at delivery had an HBV DNA level of less than 10

Indexed as

AdultAntiviral AgentsFemaleHepatitis BHepatitis B virusHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMaleMothersPregnancyPregnancy Complications, InfectiousProspective StudiesSafetyTreatment OutcomeAntiviral Agents

Identifiers

PMID32788743
PMCPMC7423885
OpenAlexW3048675519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.